I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
García‐Calduch, Olga
9
results:
Search for persons
X
Format
Online (9)
Mediatypes
Articles (Online) (4)
OpenAccess-fulltext (5)
Sorted by: Relevance
Sorted by: Year
?
1
Results of the compassionate program of inotuzumab ozogamic..:
Torrent, Anna
;
Morgades, Mireia
;
García‐Calduch, Olga
...
European Journal of Haematology. 111 (2023) 3 - p. 485-490 , 2023
Link:
https://doi.org/10.1111/..
?
2
Feasibility and outcomes after dose reduction of immunochem..:
Ribera, Josep-Maria
;
Morgades, Mireia
;
Garcia-Calduch, Olga
...
Haematologica. 109 (2023) 2 - p. 543-552 , 2023
Link:
https://doi.org/10.3324/..
?
3
P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMU..:
Maria Ribera, Josep
;
Morgades, Mireia
;
García-Calduch, Olga
...
HemaSphere. 7 (2023) S3 - p. e813564b , 2023
Link:
https://doi.org/10.1097/..
?
4
Ponatinib, chemotherapy, and transplant in adults with Phil..:
Ribera, Josep-Maria
;
García-Calduch, Olga
;
Ribera, Jordi
...
Blood Advances. 6 (2022) 18 - p. 5395-5402 , 2022
Link:
https://doi.org/10.1182/..
?
5
P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMU..:
Maria Ribera, Josep
;
Morgades, Mireia
;
García-Calduch, Olga
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431106/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
6
P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMU..:
Josep Maria Ribera
;
Mireia Morgades
;
Olga García-Calduch
...
http://journals.lww.com/10.1097/01.HS9.0000971484.81356.4b. , 2023
Link:
https://doi.org/10.1097/..
?
7
Ponatinib, chemotherapy, and transplant in adults with Phil..:
Ribera, Jose-Maria
;
García-Calduch, Olga
;
Ribera, Jordi
...
Ministerio de Economía y Competitividad PI14/01971. , 2022
Link:
https://ddd.uab.cat/reco..
?
8
Ponatinib, chemotherapy, and transplant in adults with Phil..:
Ribera, Josep-Maria
;
García-Calduch, Olga
;
Ribera, Jordi
...
http://hdl.handle.net/10668/20253. , 2022
Link:
http://hdl.handle.net/10..
?
9
Ponatinib, chemotherapy, and transplant in adults with Phil..:
Ribera, Josep-Maria
;
García-Calduch, Olga
;
Ribera, Jordi
...
#PLACEHOLDER_PARENT_METADATA_VALUE#. , 2022
Link:
http://hdl.handle.net/10..
1-9